Literature DB >> 7738939

The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher.

E M Badley.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7738939

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

Review 1.  International variation in hip replacement rates.

Authors:  H Merx; K Dreinhöfer; P Schräder; T Stürmer; W Puhl; K-P Günther; H Brenner
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

Review 2.  International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review.

Authors:  Hubertus Rosery; Rito Bergemann; Stefanie Maxion-Bergemann
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings.

Authors:  D P Lubeck
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Impact of musculoskeletal disorders on quality of life: an inception cohort study.

Authors:  C H Roux; F Guillemin; S Boini; F Longuetaud; N Arnault; S Hercberg; S Briançon
Journal:  Ann Rheum Dis       Date:  2004-12-02       Impact factor: 19.103

5.  Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997.

Authors:  Edward Yelin; Louise Murphy; Miriam G Cisternas; Aimee J Foreman; David J Pasta; Charles G Helmick
Journal:  Arthritis Rheum       Date:  2007-05

6.  Lifetime risk of symptomatic knee osteoarthritis.

Authors:  Louise Murphy; Todd A Schwartz; Charles G Helmick; Jordan B Renner; Gail Tudor; Gary Koch; Anca Dragomir; William D Kalsbeek; Gheorghe Luta; Joanne M Jordan
Journal:  Arthritis Rheum       Date:  2008-09-15

7.  Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.

Authors:  Louise Profit; Paul Chrisp
Journal:  Core Evid       Date:  2007-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.